Literature DB >> 2284495

Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells.

M V Clément1, P Haddad, A Soulié, S Legros-Maida, J Guillet, E Cesar, M Sasportes.   

Abstract

Natural killer (NK) cells (CD3-) or large granular lymphocytes (LGL) spontaneously kill K562 targets but are unable to kill Daudi cells in the absence of IL-2 stimulation. IL-4 is reported to prevent or inhibit the IL-2-driven lymphokine-activated killer (LAK) generation in NK cells. Therefore, we wished to determine whether the antagonistic effect of IL-4 on IL-2-induced LAK activity might regulate the expression of genes encoding proteins involved in lysis, such as perforin, the pore-forming protein, or which are associated with lysis, such as granzymes A and B. By using in situ hybridization, we showed that, in addition to inducing LAK activity, IL-2 stimulation increased the amount of perforin and granzyme B mRNA at the single-cell level in 40 to 100% of the total CD3- LGL cell population. In addition, our results indicated that the stimulatory effect of IL-2 can be downregulated by IL-4 for both LAK activity and granzyme B and perforin gene expression. Here again, a decrease in the amount of specific mRNA per cell was noted. These findings suggest that modulation of the lytic machinery via lymphokines might be associated with regulation of the lytic potential of NK cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2284495     DOI: 10.1016/0923-2494(90)90017-s

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


  8 in total

1.  In vitro atrazine-exposure inhibits human natural killer cell lytic granule release.

Authors:  Alexander M Rowe; Kathleen M Brundage; John B Barnett
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-07       Impact factor: 4.219

Review 2.  Laboratory diagnosis of primary immunodeficiencies.

Authors:  Bradley A Locke; Trivikram Dasu; James W Verbsky
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

3.  Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection.

Authors:  Ashlesh K Murthy; Weidang Li; Bharat K R Chaganty; Sangamithra Kamalakaran; M Neal Guentzel; J Seshu; Thomas G Forsthuber; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

4.  Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.

Authors:  Yuying Liu; Weihe Zhang; Ting Niu; Lawrence H Cheung; Anupama Munshi; Raymond E Meyn; Michael G Rosenblum
Journal:  Neoplasia       Date:  2006-02       Impact factor: 5.715

5.  Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression.

Authors:  Alan Long; Donye Dominguez; Lei Qin; Siqi Chen; Jie Fan; Minghui Zhang; Deyu Fang; Yi Zhang; Timothy M Kuzel; Bin Zhang
Journal:  J Immunol       Date:  2018-10-29       Impact factor: 5.422

6.  Granulysin-mediated tumor rejection in transgenic mice.

Authors:  Lisa P Huang; Shu-Chen Lyu; Carol Clayberger; Alan M Krensky
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.426

7.  Natural killer cells: role in local tumor growth and metastasis.

Authors:  Inge Langers; Virginie M Renoux; Marc Thiry; Philippe Delvenne; Nathalie Jacobs
Journal:  Biologics       Date:  2012-04-05

Review 8.  An Inflammatory Story: Antibodies in Tuberculosis Comorbidities.

Authors:  Milla R McLean; Lenette L Lu; Stephen J Kent; Amy W Chung
Journal:  Front Immunol       Date:  2019-12-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.